Adherence to Long-Term Therapies - Evidence for Action
(2003; 211 pages) Voir le document au format PDF
Table des matières
Afficher le documentPreface
Afficher le documentAcknowledgements
Afficher le documentScientific writers
Afficher le documentIntroduction
Afficher le documentTake-home messages
Ouvrir ce répertoire et afficher son contenuSection I - Setting the scene
Ouvrir ce répertoire et afficher son contenuSection II - Improving adherence rates: guidance for countries
Fermer ce répertoireSection III - Disease-Specific Reviews
Ouvrir ce répertoire et afficher son contenuChapter VII - Asthma
Ouvrir ce répertoire et afficher son contenuChapter VIII - Cancer (Palliative care)
Ouvrir ce répertoire et afficher son contenuChapter IX - Depression
Ouvrir ce répertoire et afficher son contenuChapter X - Diabetes
Ouvrir ce répertoire et afficher son contenuChapter XI - Epilepsy
Ouvrir ce répertoire et afficher son contenuChapter XII - Human immunodeficiency virus and acquired immunodeficiency syndrome
Ouvrir ce répertoire et afficher son contenuChapter XIII - Hypertension
Fermer ce répertoireChapter XIV - Tobacco smoking cessation
Afficher le document1. The burden of tobacco smoking
Afficher le document2. Clinical guidelines and therapies available for tobacco smoking cessation
Afficher le document3. Definitions
Afficher le document4. Epidemiology of adherence
Afficher le document5. Factors affecting adherence
Afficher le document6. Interventions for improving adherence
Afficher le document7. Cost, effectiveness and cost-effectiveness of adherence
Afficher le document8. Conclusions
Afficher le document9. References
Ouvrir ce répertoire et afficher son contenuChapter XV - Tuberculosis
Ouvrir ce répertoire et afficher son contenuAnnexes
Ouvrir ce répertoire et afficher son contenuWhere to find a copy of this book
 

6. Interventions for improving adherence

The most frequently employed interventions for improving adherence reviewed were NRT, antidepressant therapy, pharmacist intervention, psychosocial/behavioural support and counselling, and diet counselling (low-calorie diet) (see also Table 9). Adjunctive psychosocial treatment or behavioural advice has been successfully used to support smoking cessation programmes (25).

Although Alterman et al. showed that patients receiving more intense adjunctive psychosocial or medical treatment were more adherent to treatment with patches (25), overall, the data reviewed suggested that minimal behavioural support also results in similar or higher adherence rates, at least for some types of smoker. Minimal behavioural support might offer a cost-effective way to implement first-line smoking cessation programmes at a population level. More controlled studies including cost-effectiveness analysis are needed to clarify this issue.

The monitoring of therapeutic drug levels, NRT and/or antidepressant may also be useful. This feedback might be used to identify poorly adherent patients for whom more intensive adherence-enhancing interventions would be helpful (46).

Intensive anti-smoking campaigns, such as the "Truth Denormalization Ads" might be extremely useful, especially among teenagers, as they change the social attitude towards tobacco smoking.

Table 9 Factors affecting adherence to smoking cessation therapy and interventions for improving it, listed by the five dimensions and the interventions used to improve adherence

Tobacco smoking

Factors affecting adherence

Interventions to improve adherence

Socioeconomic-related factors

(-) High treatment cost (41)

(+) Higher education levels, older age (41)

Social assistance (25)

Health care team/health system-related factors

(-) Unavailability for follow up or lost to follow up (1,8,10,11,17,21); failure to recall the receipt of a prescription (20)

(+) Access to free NRT; more frequent contact with physicians and pharmacists (35)

Pharmacist mobilization (41); access to free NRT; frequent follow-up interviews (35)

Condition-related factors

(-) Daily cigarette consumption; expired CO, plasma nicotine and cotinine levels; Fagerstrom Tolerance Questionnaire (FTQ) scores (44); greater tobacco dependence (25); psychiatric comorbidities; depression (3,25); failure to stop or reduce smoking during treatment (1,3,8 - 10,17,18,21,22,24,29,36 - 38,41 - 43)

Education on use of medications; supportive psychiatric consultation (3,25)

Therapy-related factors

(+) Attendance at behavioural intervention sessions (26); adverse events (1,9,16,37 - 40) or withdrawal symptoms (1,9,11,12,13,16 - 18,22,35 - 40)

NRT; antidepressant therapy; education on use of medications; adherence education; assistance with weight reduction (29); continuous monitoring and reassessment of treatment; monitoring adherence (46)

Patient-related factors

(-) Weight gain (29)

(+) Motivation (25); good relationship between patient and physician (41)

Adjunctive psychosocial treatment; behavioural intervention (1,9 - 13,16 - 19,21 - 23,25,29,30,32,38,39,47 - 52); assistance with weight reduction (29); good patient - physician relationship (41)

 

CO, Carbon monoxide; NRT, nicotine replacement therapy; (+) factors having a positive effect on adherence; (-) factors having a negative effect on adherence.

vers la section précédente vers la section suivante
 

Dernière mise à jour: le 3 mai 2013